| Title | [Triptans versus other migraine medicine - secondary publication] | | Author(s) | Tfelt-Hansen P | | Institution | Dansk Hovedpinecenter, Neurologisk Afdeling, Glostrup Hospital. ptha@glo.regionh.dk | | Source | Ugeskr Laeger 2009 Apr 27; 171(18):1485-7. | | Abstract | The introduction of triptans in the treatment of migraine was apparently a revolution.Comparative randomised trials do not, however, show a clearcut picture.Oral triptans outperform oral ergotamine most because of the extremely low (< 1%) oral bioavailability of ergotamine. Compared with NSAIDs, triptants are not, in most cases, superior to aspirin. Aspirin is suggested as first-choice drug in migraine treatment. An additional advantage of aspirin is that is it much less expensive than triptans. | | Language | dan | | Pub Type(s) | English Abstract
Journal Article
| | PubMed ID | 19425262 |
|
